These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
372 related items for PubMed ID: 9681391
21. [Tumor necrosis factor alpha and its soluble receptors in serum of patients with coronary artery disease]. Mizia-Stec K, Mandecki T, Zahorska-Markiewicz B, Janowska J, Szulc A, Jastrzebska-Maj E, Szymański L. Pol Merkur Lekarski; 2001 Jul; 11(61):19-25. PubMed ID: 11579824 [Abstract] [Full Text] [Related]
22. Changes in sIL-6R and sTNF-Rs release by PMNs and the serum levels in breast cancer patients at different stages of treatment. Jablonska E. Cytokine; 1998 Jul; 10(7):540-3. PubMed ID: 9702418 [Abstract] [Full Text] [Related]
23. Serum values of tumour necrosis factor-alpha and of soluble tumour necrosis factor-R55 in melanoma patients. Ocvirk J, Stabuc B, Rudolf Z, Galvani V, Curin-Serbec V. Melanoma Res; 2000 Jun; 10(3):253-8. PubMed ID: 10890379 [Abstract] [Full Text] [Related]
24. Soluble IL-6 receptor release by PMNs and PBMC in patients with oral cavity cancer. Jabłońska E, Piotrowski L, Grabowska Z. Rocz Akad Med Bialymst; 1997 Jun; 42(1):99-106. PubMed ID: 9581469 [Abstract] [Full Text] [Related]
25. Effects of an intravenous catheter on the local production of cytokines and soluble cytokine receptors in healthy men. Haack M, Reichenberg A, Kraus T, Schuld A, Yirmiya R, Pollmächer T. Cytokine; 2000 Jun; 12(6):694-8. PubMed ID: 10843747 [Abstract] [Full Text] [Related]
26. [Soluble TNF and IL-2 receptors in patients with breast carcinoma]. Tesarová P, Kvasnicka J, Umlaufová A, Homolková J, Jirsa M, Tesar V. Cas Lek Cesk; 1998 May 25; 137(11):341-5. PubMed ID: 9727208 [Abstract] [Full Text] [Related]
27. Further observations on the fetal inflammatory response syndrome: a potential homeostatic role for the soluble receptors of tumor necrosis factor alpha. Romero R, Maymon E, Pacora P, Gomez R, Mazor M, Yoon BH, Berry SM. Am J Obstet Gynecol; 2000 Nov 25; 183(5):1070-7. PubMed ID: 11084543 [Abstract] [Full Text] [Related]
28. [Changes of proinflammatory cytokines and their receptors in serum from patients with pulmonary tuberculosis]. Tang S, Xiao H, Fan Y, Wu F, Zhang Z, Li H, Yang Y. Zhonghua Jie He He Hu Xi Za Zhi; 2002 Jun 25; 25(6):325-9. PubMed ID: 12126553 [Abstract] [Full Text] [Related]
29. Serum levels of soluble receptors for tumor necrosis factor (p55 and p75 sTNFr) in endometrial cancer. Gadducci A, Ferdeghini M, Fanucchi A, Annicchiarico C, Prato B, Prontera C, Facchini V, Genazzani AR. Anticancer Res; 1996 Jun 25; 16(5B):3125-8. PubMed ID: 8920779 [Abstract] [Full Text] [Related]
30. [Soluble TNF p55 and p75 receptors in the development of sepsis syndrome]. Modzelewski B. Pol Merkur Lekarski; 2003 Jan 25; 14(79):69-72. PubMed ID: 12712835 [Abstract] [Full Text] [Related]
31. Release of tumor necrosis factor alpha and its soluble receptor p55 in clinical septic syndrome. Modzelewski B. Arch Immunol Ther Exp (Warsz); 1997 Jan 25; 45(2-3):213-9. PubMed ID: 9597089 [Abstract] [Full Text] [Related]
32. Tumor necrosis factor (TNF)-alpha-induced interleukin-8 in human blood cultures discriminates neutralization by the p55 and p75 TNF soluble receptors. Frishman JI, Edwards CK, Sonnenberg MG, Kohno T, Cohen AM, Dinarello CA. J Infect Dis; 2000 Dec 25; 182(6):1722-30. PubMed ID: 11069245 [Abstract] [Full Text] [Related]
33. [Role of the TNF system in the pathomechanism of bronchial asthma]. Halász A, Cserháti E, Cseh K. Orv Hetil; 2002 Mar 17; 143(11):553-7. PubMed ID: 12583324 [Abstract] [Full Text] [Related]
34. [Study on the T lymphocytes early activation and soluble tumor necrosis factor receptor in patients with aplastic anemia]. Shen R, Xu CG, Li LZ, Zhang T, Qin XM, Li J, Zhao CL. Zhonghua Xue Ye Xue Za Zhi; 2004 Apr 17; 25(4):209-12. PubMed ID: 15182557 [Abstract] [Full Text] [Related]
35. Soluble tumor necrosis factor receptor II and soluble cell adhesion molecule 1 as markers of tumor necrosis factor-alpha release in preeclampsia. Visser W, Beckmann I, Knook MA, Wallenburg HC. Acta Obstet Gynecol Scand; 2002 Aug 17; 81(8):713-9. PubMed ID: 12174154 [Abstract] [Full Text] [Related]
36. Soluble tumor necrosis factor (TNF) receptors p55 and p75 and interleukin-10 downregulate TNF-alpha activity during the lung response to silica particles in NMRI mice. Huaux F, Arras M, Vink A, Renauld JC, Lison D. Am J Respir Cell Mol Biol; 1999 Jul 17; 21(1):137-45. PubMed ID: 10385602 [Abstract] [Full Text] [Related]
37. Polymorphonuclear granulocytes enhance lipopolysaccharide-induced soluble p75 tumor necrosis factor receptor release from mononuclear cells. Lien E, Liabakk NB, Johnsen AC, Nonstad U, Sundan A, Espevik T. Eur J Immunol; 1995 Sep 17; 25(9):2714-7. PubMed ID: 7589151 [Abstract] [Full Text] [Related]
38. Tumor necrosis factor alpha and interleukin-1 alpha stimulate late shedding of p75 TNF receptors but not p55 TNF receptors from human monocytes. Joyce DA, Steer JH. J Interferon Cytokine Res; 1995 Nov 17; 15(11):947-54. PubMed ID: 8590306 [Abstract] [Full Text] [Related]
39. Three measures of tumor necrosis factor alpha activity and insulin resistance in nonobese Japanese type 2 diabetic patients. Ohya M, Taniguchi A, Fukushima M, Nakai Y, Kawasaki Y, Nagasaka S, Kuroe A, Taki Y, Yoshii S, Hosokawa M, Inagaki N, Seino Y. Metabolism; 2005 Oct 17; 54(10):1297-301. PubMed ID: 16154427 [Abstract] [Full Text] [Related]
40. Soluble tumor necrosis factor (sTNF) receptors: a possible prognostic marker for bone marrow transplantation-related complications. Or R, Kalinkovich A, Nagler A, Weisman Z, Naparstek E, Weiss L, Hahn T. Cytokines Mol Ther; 1996 Dec 17; 2(4):243-50. PubMed ID: 9384711 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]